J&J Board Changes and Officer Compensation Updates
Ticker: JNJ · Form: 8-K · Filed: Sep 10, 2024 · CIK: 200406
| Field | Detail |
|---|---|
| Company | Johnson & Johnson (JNJ) |
| Form Type | 8-K |
| Filed Date | Sep 10, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $1.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, executive-compensation, board-of-directors
Related Tickers: JNJ
TL;DR
J&J board shake-up: Dr. JoAnn C. Smith out, Dr. Joseph M. Smith in. Officer pay details updated.
AI Summary
On September 10, 2024, Johnson & Johnson filed an 8-K report detailing changes in its board of directors and executive compensation. Specifically, the filing announced the departure of director Dr. JoAnn C. Smith and the election of new director Dr. Joseph M. Smith. Additionally, it outlined updates to the compensatory arrangements for certain officers.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — The filing primarily concerns routine corporate governance and executive compensation matters, with no immediate financial implications disclosed.
Key Players & Entities
- Johnson & Johnson (company) — Registrant
- Dr. JoAnn C. Smith (person) — Departing Director
- Dr. Joseph M. Smith (person) — Newly Elected Director
- September 10, 2024 (date) — Report Date
FAQ
Who is Dr. JoAnn C. Smith and why did she depart from the Johnson & Johnson board?
The filing states that Dr. JoAnn C. Smith departed from the board of directors of Johnson & Johnson on September 10, 2024. The specific reasons for her departure are not detailed in this 8-K filing.
What is the background of the new director, Dr. Joseph M. Smith?
The filing announces the election of Dr. Joseph M. Smith to the board of directors of Johnson & Johnson. Further details regarding his background or qualifications are not provided in this specific 8-K.
What specific changes were made to the compensatory arrangements for certain officers?
The 8-K filing indicates that there were updates to the compensatory arrangements of certain officers, but the specific details of these arrangements are not elaborated upon in this document.
What is the significance of the 'Departure of Directors or Certain Officers' item in this filing?
This item signifies that there have been changes in the company's leadership, specifically the departure of a director and the election of a new one, which is a mandatory disclosure for public companies.
Are there any financial implications mentioned regarding the board changes or compensation updates?
This 8-K filing does not explicitly mention any immediate financial implications stemming from the director changes or the updates to officer compensation arrangements.
Filing Stats: 501 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2024-09-10 16:26:10
Key Financial Figures
- $1.00 — ich registered Common Stock, Par Value $1.00 JNJ New York Stock Exchange 5.50% Note
Filing Documents
- jnj-20240910.htm (8-K) — 33KB
- 0000200406-24-000081.txt ( ) — 224KB
- jnj-20240910.xsd (EX-101.SCH) — 4KB
- jnj-20240910_def.xml (EX-101.DEF) — 8KB
- jnj-20240910_lab.xml (EX-101.LAB) — 33KB
- jnj-20240910_pre.xml (EX-101.PRE) — 20KB
- jnj-20240910_htm.xml (XML) — 8KB
01 Financial statements and exhibits
Item 9.01 Financial statements and exhibits (d) Exhibits. Exhibit No. Description of Exhibit 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
Signatures
Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 10, 2024 JOHNSON & JOHNSON (Registrant) By: /s/ Marc Larkins Marc Larkins Corporate Secretary